The stock price of Albertsons Companies Inc (NYSE: ACI) has surged by 3.39 when compared to previous closing price of 21.08, but the company has seen a 3.05% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-13 that AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potential milestones of up to about $2.1 billion plus royalties on sales upon commercialization ACI-24.060 ABATE Phase 1b/2 trial showed encouraging interim safety and tolerability data in Down syndrome (DS) cohort; further interim results in Alzheimer’s disease (AD) and DS expected in 2025 Enrollment progress in JNJ-2056 (ACI-35.030) ReTain Phase 2b trial in preclinical AD patients triggered second milestone payment of CHF 24.6 million; JNJ-2056 granted U.S. FDA Fast Track Designation in AD ACI-7104.056 VacSYn Phase 2 trial demonstrated positive interim safety and immunogenicity results in Parkinson’s disease (PD); further interim results in H1 2025 Cash resources of CHF 165.5 million at year end provides funding into Q1 2027, assuming no other milestones Lausanne, Switzerland, March 13, 2025 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today reported results for the full year ended December 31, 2024, and provided a corporate update. Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “We significantly advanced our leading position in the precision prevention of neurodegenerative diseases in 2024 through strong pipeline progress and the closing of a landmark deal with Takeda.
Is It Worth Investing in Albertsons Companies Inc (NYSE: ACI) Right Now?
The price-to-earnings ratio for Albertsons Companies Inc (NYSE: ACI) is above average at 12.25x. The 36-month beta value for ACI is also noteworthy at 0.49. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 6 rating it as “overweight,” 10 rating it as “hold,” and 0 rating it as “sell.”
The public float for ACI is 418.99M, and at present, short sellers hold a 2.20% of that float. The average trading volume of ACI on March 17, 2025 was 6.65M shares.
ACI’s Market Performance
The stock of Albertsons Companies Inc (ACI) has seen a 3.05% increase in the past week, with a 2.13% rise in the past month, and a 19.56% gain in the past quarter. The volatility ratio for the week is 2.95%, and the volatility levels for the past 30 days are at 2.44% for ACI. The simple moving average for the past 20 days is 4.50% for ACI’s stock, with a 10.86% simple moving average for the past 200 days.
Analysts’ Opinion of ACI
Many brokerage firms have already submitted their reports for ACI stocks, with Goldman repeating the rating for ACI by listing it as a “Buy.” The predicted price for ACI in the upcoming period, according to Goldman is $26 based on the research report published on February 04, 2025 of the current year 2025.
Citigroup, on the other hand, stated in their research note that they expect to see ACI reach a price target of $26. The rating they have provided for ACI stocks is “Buy” according to the report published on January 24th, 2025.
Telsey Advisory Group gave a rating of “Outperform” to ACI, setting the target price at $26 in the report published on December 17th of the previous year.
ACI Trading at 6.41% from the 50-Day Moving Average
After a stumble in the market that brought ACI to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.58% of gains for the given period.
Volatility was left at 2.44%, however, over the last 30 days, the volatility rate increased by 2.95%, as shares surge +4.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.90% upper at present.
During the last 5 trading sessions, ACI rose by +2.98%, which changed the moving average for the period of 200-days by +6.97% in comparison to the 20-day moving average, which settled at $20.85. In addition, Albertsons Companies Inc saw 10.97% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ACI starting from Larson Robert Bruce, who sale 24,362 shares at the price of $20.24 back on May 01 ’24. After this action, Larson Robert Bruce now owns 50,241 shares of Albertsons Companies Inc, valued at $493,087 using the latest closing price.
DHANDA ANUJ, the Chief Tech &Transformation Off of Albertsons Companies Inc, sale 100,000 shares at $20.35 during a trade that took place back on Apr 30 ’24, which means that DHANDA ANUJ is holding 365,297 shares at $2,035,000 based on the most recent closing price.
Stock Fundamentals for ACI
Current profitability levels for the company are sitting at:
- 0.02 for the present operating margin
- 0.28 for the gross margin
The net margin for Albertsons Companies Inc stands at 0.01. The total capital return value is set at 0.1. Equity return is now at value 35.20, with 3.90 for asset returns.
Based on Albertsons Companies Inc (ACI), the company’s capital structure generated 0.81 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 4.22. The interest coverage ratio of the stock is 3.99.
Currently, EBITDA for the company is 4.54 billion with net debt to EBITDA at 4.08. When we switch over and look at the enterprise to sales, we see a ratio of 0.33. The receivables turnover for the company is 86.04for trailing twelve months and the total asset turnover is 3.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.93.
Conclusion
In summary, Albertsons Companies Inc (ACI) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
